Roche's Strategic Shift: Partnering with Chinese Biotech for Drug Discovery
Roche is redefining its strategy in China by partnering with Defand Therapeutics to focus on discovering new medicines rather than merely licensing existing candidates.
Tailoring Breast Cancer Treatments for Older Women: A New Approach
As older women often miss out on essential clinical trials, tailored breast cancer treatments may hold the key to better care for this demographic.
02New Study Highlights Potential Drawbacks of Vitamin D2 Over Vitamin D3 Supplementation
Recent research shows taking vitamin D2 may lower natural vitamin D3 levels in the body, emphasizing the importance of choosing the right supplement.
03Optogenetics Offers New Hope for Retinitis Pigmentosa Patients
A recent study highlights optogenetics as a promising intervention for restoring vision in patients with retinitis pigmentosa, a degenerative eye disorder.
04Forbion Secures $2.6 Billion in Record Funding Boost for Biotech Endeavors
Forbion achieves its largest fundraising milestone to date, raising $2.6 billion to accelerate its biotech investments.
05Breakthrough Neuroscience Study Links Cannabinoids to Anxiety Responses in Mice
A recent study reveals specific neurons in the brain linked to anxiety caused by cannabinoids, shedding light on both drug effects and potential treatments.
06AstraZeneca Expands Presence with New Boston Facility
AstraZeneca has unveiled a new facility in Boston, marking a significant expansion in its U.S. operations and commitment to biotech innovation.
07Pulse Oximeter Accuracy Dilemma: A Shift from Overestimation to Underestimation at Johns Hopkins
A recent study highlights shifting accuracy in pulse oximeters at Johns Hopkins, raising concerns about their reliability for all skin tones.
08Advancements in Optogenetics Propel Experimental Therapies for Blindness and Alzheimer’s
Research in optogenetics has gained momentum following a Nobel Prize win, opening doors for potential treatments for blindness and Alzheimer's.
09Lilly's Jaypirca Secures Approval as First-Line Treatment for CLL
Lilly's new therapy, Jaypirca, has received FDA approval as the first-line treatment for chronic lymphocytic leukemia (CLL), marking a significant advancement in care.
10Exploring the Potential of Cancer Vaccines: Recent Advances and Challenges
The recent developments in cancer vaccines highlight both promise and challenges, raising questions about their effectiveness across various cancer types.
11Nobel Prize in Medicine 2026 Honors Pioneers of Optogenetics
The 2026 Nobel Prize in Medicine recognizes Karl Deisseroth, Peter Hegemann, and Georg Nagel for their transformative work in optogenetics.
12Stem Cell Entrepreneurs Anticipate FDA’s Shift Towards Regulation
Industry leaders foresee FDA action on stem cell therapies, spurred by recent developments in peptide regulations, signaling potential market changes.
13The Future of AI in Medicine: Will Machines Earn Nobel Recognition?
As AI increasingly aids medical discoveries, questions arise about recognition and credit for breakthroughs, potentially reshaping the scientific landscape.
14The Anticipation of Nobel Recognition: Insights from Mary-Claire King
Geneticist Mary-Claire King reflects on the anticipation of Nobel Prize consideration and the impact of her work on breast and ovarian cancer.